CERT1
Ceramide transfer protein
Also known as: CERT, CERT_HUMAN, COL4A3BP, GPBP, STARD11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5P4
- Gene
- CERT1
- Ensembl
- ENSG00000113163
- Chromosome
- 5
- Canonical length
- 624 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a kinase that specifically phosphorylates the N-terminal region of the non-collagenous domain of the alpha 3 chain of type IV collagen, known as the Goodpasture antigen. Goodpasture disease is the result of an autoimmune response directed at this antigen. One isoform of this protein is also involved in ceramide intracellular transport. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
624 residues, UniProt reviewed canonical sequence.
>Q9Y5P4|CERT1
1 MSDNQSWNSS GSEEDPETES GPPVERCGVL SKWTNYIHGW QDRWVVLKNN ALSYYKSEDE
61 TEYGCRGSIC LSKAVITPHD FDECRFDISV NDSVWYLRAQ DPDHRQQWID AIEQHKTESG
121 YGSESSLRRH GSMVSLVSGA SGYSATSTSS FKKGHSLREK LAEMETFRDI LCRQVDTLQK
181 YFDACADAVS KDELQRDKVV EDDEDDFPTT RSDGDFLHST NGNKEKLFPH VTPKGINGID
241 FKGEAITFKA TTAGILATLS HCIELMVKRE DSWQKRLDKE TEKKRRTEEA YKNAMTELKK
301 KSHFGGPDYE EGPNSLINEE EFFDAVEAAL DRQDKIEEQS QSEKVRLHWP TSLPSGDAFS
361 SVGTHRFVQK PYSRSSSMSS IDLVSASDDV HRFSSQVEEM VQNHMTYSLQ DVGGDANWQL
421 VVEEGEMKVY RREVEENGIV LDPLKATHAV KGVTGHEVCN YFWNVDVRND WETTIENFHV
481 VETLADNAII IYQTHKRVWP ASQRDVLYLS VIRKIPALTE NDPETWIVCN FSVDHDSAPL
541 NNRCVRAKIN VAMICQTLVS PPEGNQEISR DNILCKITYV ANVNPGGWAP ASVLRAVAKR
601 EYPKFLKRFT SYVQEKTAGK PILFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CERT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 47 nTPM
- adipose tissue: 36 nTPM
- skeletal muscle: 33 nTPM
- cervix: 32 nTPM
- liver: 29 nTPM
- testis: 27 nTPM
Single-cell type
- neutrophils: 716 nCPM
- neutrophil progenitors: 573 nCPM
- adipocytes: 279 nCPM
- monocytes: 274 nCPM
- respiratory basal cells: 269 nCPM
- mast cells: 249 nCPM
Immune cell
- neutrophil: 29 nTPM
- non-classical monocyte: 25 nTPM
- intermediate monocyte: 22 nTPM
- classical monocyte: 20 nTPM
- eosinophil: 16 nTPM
- myeloid DC: 14 nTPM
Brain region
- cerebellum: 40 nTPM
- midbrain: 40 nTPM
- white matter: 38 nTPM
- pons: 38 nTPM
- basal ganglia: 36 nTPM
- hypothalamus: 36 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CERT1.
Disease | AllUniProt
Conditions CERT1 is implicated in, by any mechanism.
- Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies (NEDHSF) MIM:616351
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 273 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, autosomal dominant 34
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.67
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell morphogenesis
- cell population proliferation
- ceramide metabolic process
- ceramide transport
- endoplasmic reticulum organization
- ER to Golgi ceramide transport
- heart morphogenesis
- immune response
- in utero embryonic development
- intermembrane lipid transfer
- lipid homeostasis
- mitochondrion organization
- muscle contraction
- response to endoplasmic reticulum stress
- signal transduction
- sphingomyelin biosynthetic process
- intermembrane sphingolipid transfer
Molecular functions
- ceramide 1-phosphate binding
- ceramide 1-phosphate transfer activity
- ceramide binding
- ceramide transfer activity
- identical protein binding
- kinase activity
- lipid transfer activity
- phosphatidylinositol-4-phosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CERT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CERT1 as an antibody target. Whether an autoantibody or antibody against CERT1 could matter depends on whether native CERT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CERT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Goodpasture disease is the result of an autoimmune response directed at this antigen.
Loading the interactive Seroatlas protein explorer...